IgM MGUS
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy (NCT05065554) | Shayna Sarosiek, MD | 2021-11-16 |
Track IgM MGUS automatically
Every clearance here is in the API, with alerts when new ones post.